AM Best Affirms The Doctors Company's ‘A' Excellent Financial Rating and Upgrades the Financial Rating of Hospitals Insurance Company to ‘A’
September 6, 2023: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
Search
Jun 18, 2024
From the President: TDC Group Appoints Daniel Kent Cassavar, MD, MBA, as Medical Director
President Robert E. White, Jr., announces the appointment of Daniel Kent Cassavar, MD, MBA, as Medical Director of TDC Group.
From
The Doctor’s Advocate
New York Regional Society of Plastic Surgeons Selects The Doctors Company as Exclusive Partner
The New York Regional Society of Plastic Surgeons (NYRSPS) has chosen The Doctors Company, part of TDC Group, as the exclusively endorsed medical malpractice insurer for its members.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Video Aug 29, 2025
A Giant Leap: Lessons From the Early Days of Gen AI in Healthcare
Robert M. Wachter, MD, Internist; Chair, Department of Medicine, UCSF; and Member, Board of Governors, The Doctors Company, presents at the 2025 TDC Group Executive Advisory Board Meeting about how healthcare has been transformed in the early days of artificial intelligence.
January 31, 2025, PSQH: The Podcast
PSQH: The Podcast Episode 122 – The Growing Role of Advanced Practice Clinicians
Laura Kline, MBA, CPCU, Senior Vice President of Business Development for The Doctors Company and TDC Group, discusses how nurse practitioners and physician assistants are taking on greater responsibility in primary care delivery. These expanded roles offer opportunities for all members of the healthcare delivery team to operate at the top of their licenses.
The Malpractice Experience of Orthopedic Surgeons 2011 to 2021: Patient Selection and Communication May Mitigate Risk of Claims
This study analyzed 1559 closed medical malpractice claims and suits (814 ambulatory, 745 inpatient) from the loss years of 2011 to 2021 in which orthopedic surgeons were the major responsible service.
An “Epidemic” of Medical Malpractice? A Commentary on the Harvard Medical Practice Study
Both supporters and opponents of malpractice legal reform can agree that the Harvard study provides us with a wealth of valuable data on questions of medical negligence. More than with most studies, however, the Harvard group’s results are subject to sharply different interpretations and depend heavily on definitions and assumptions with which many will differ.
The Doctors Company Announces $8.5 Million Member Dividend
We are proud to announce The Doctors Company has approved a 2023 premium dividend of approximately $8.5 million, bringing the total of declared dividends to date to more than $455 million.
Study of Emergency Department Diagnosis Case Type Malpractice Claims: Abstract
A study of diagnosis-type closed medical malpractice claims from care that occurred in the ED from 2014 through the second quarter of 2019 using closed coded claims from The Doctors Company.
